Coriolis Pharma announced a $10 million investment to establish its U.S. headquarters in Morrisville, creating 50 high-paying jobs over the next five years. As the first anchor tenant at Spark Life Sciences, they will occupy 13,000 square feet of laboratory space, offering drug product development and manufacturing services. Founded in 2008 in Germany, Coriolis Pharma is a global leader in biopharmaceutical drug development.
The facility, set to open in the first quarter of 2026, will create 50 new jobs and provide specialized services like particle identification, formulation development, and lyophilization, strengthening the company\'s North American presence and support for biopharmaceutical clients.\
Key Details\
- Investment:\ $10 million
- Location:\ Spark LS life science campus in Morrisville, North Carolina
- Facility Size:\ 13,000-square-foot research laboratory
- Jobs Created:\ 50
- Opening:\ First quarter of 2026
Services Offered
The new laboratory will initially focus on core services and expand over time:\ particle identification, formulation development, and lyophilization.\
Strategic Importance
- .The Morrisville location will serve as Coriolis Pharma\'s U.S. headquarters, providing on-site services for North American clients.\
- .The company chose Morrisville due to its strong biotechnology ecosystem and talent pool, reflecting the region\'s growing importance in the life sciences.\
- .The facility will incorporate advanced digital and in-silico technologies to accelerate drug development timelines.\


